Prosecution Insights
Last updated: July 17, 2026

Ice Miller LLP

105 pending office actions • 76 clients • 96 examiners • 68 art units • 0 of 105 (0%) have an AI response strategy ready • 197 patents granted in the last 365 days

Quality Metrics (n=8912 apps, methodology: how we score firms)

80.9%
Allowance Rate
n=8912
+0.51σ
Allowance Rate (norm)
n=8912
3.1
OAs to Allowance
n=4056
-0.17σ
OAs to Allow (norm)
n=4056
993 days
Time to Allowance
n=4056
+11.6pp
Interview Lift
n=8912
22.0%
RCE Rate
n=8912
2.0%
Appeal Rate
n=8912

Rejection Performance (% of received rejections ultimately overcome)

68.6%
§101 Overcome
n=124
80.3%
§102 Overcome
n=473
75.0%
§103 Overcome
n=1960
87.1%
§112 Overcome
n=590

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
21%
Top-3 CPC Share
n=8912
18
Practitioners
n=8912
495.1
Apps / Practitioner
n=8912

Portfolio Summary

105
Total Pending OAs
66
Non-Final OAs
33
Final Rejections
6
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 59 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

24
Overdue
2
Due this week
16
Due this month
9
Due in next 60 days
8
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 59 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (24)Due ≤ 7 days (2)Due ≤ 30 days (16)Due ≤ 60 days (9)Due later (8)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (8%)
67
Medium (64%)
21
Easy (20%)
9
Unknown (9%)

Rejection Statute Mix

BucketCases
§101 only8 (8%)
§103 only56 (53%)
§102 only9 (9%)
§112 only12 (11%)
Double-patenting only9 (9%)
Double-patenting + other2 (2%)
No statute on record9 (9%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

56
Life Sciences
53% of docket
6
Information Tech
6% of docket
1
Communications
1% of docket
3
Semiconductors
3% of docket
30
Mechanical / Eng
29% of docket
9
Business / Other
9% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,050 h
Manual time on pending OAs
210 h
Time saved (low, 20%)
368 h
Time saved (mid, 35%)
9.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZEROUAL, OMAR 4 33.7% +39.9%
HOFFA, ANGELA MARIE 3 67.6% +27.4%
PRASAD, NANCY N 2 21.5% +18.2%
STOCKTON, LAURA LYNNE 2 75.1% +33.7%
HAGHIGHATIAN, MINA 2 45.8% +39.7%
THOMPSON, CURTIS A 2 61.7% +49.9%
NGUYEN, MERILYN P 1 87.1% +5.1%
OBAID, FATEH M 1 67.8% +35.6%
NGUYEN, HOANG M 1 75.9% +16.3%
WALTON, CHESIREE A 1 30.0% +28.8%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19258861 SYSTEMS AND METHODS FOR MANAGING AGNOSTIC DATA FORMS FOR VENDORS NGUYEN, MERILYN P 55d

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17284909 ITERATIVE, MULTI-USER SELECTION AND WEIGHTING RECOMMENDATION ENGINE KANG, TIMOTHY J 97d overdue
18929277 SYSTEMS AND METHODS TO ORGANIZE DATA FROM MULTIPLE PLATFORMS WITH NON-TRANSITORY COMPUTER-READABLE MEDIA AND DATA ORGANIZING METHODS EL-CHANTI, KARMA AHMAD 23d overdue
19002457 DATA RESTORE SYSTEM GUYTON, PHILIP A 3d overdue
18538630 FAI MODEL DRIVEN RECOMMENDATION SYSTEM AND METHOD LOHARIKAR, ANAND R 6d
18556605 Validating Elements Displayed on a Display Fixture BAGGOT, BREFFNI 28d
18829232 SYSTEMS AND METHODS FOR GENERATING AI-DRIVEN INTEGRATED INSIGHTS PRASAD, NANCY N 53d
18768971 SYSTEMS AND METHODS FOR DISTRIBUTION MANAGEMENT INCLUDING SPECIAL PRICING DETERMINATION NELSON, FREDA ANN 60d
18436903 SYSTEM AND METHOD FOR CONSOLIDATION, RECONCILIATION AND PAYMENT MANAGEMENT POINVIL, FRANTZY 84d

Interview Candidates (18)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17259992 USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION THOMPSON, CURTIS A 5d overdue
17260000 USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION THOMPSON, CURTIS A 5d overdue
17759807 PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND STOCKTON, LAURA LYNNE 3d overdue
17998234 COMPOUNDS AS BCL-2 INHIBITORS STOCKTON, LAURA LYNNE 22d
19102063 PUMP FOR A ZONED HEATING OR COOLING SYSTEM AND METHOD FOR CONTROLLING A PUMP NGUYEN, HOANG M 28d
18829232 SYSTEMS AND METHODS FOR GENERATING AI-DRIVEN INTEGRATED INSIGHTS PRASAD, NANCY N 53d
17975924 INJECTABLE EPINEPHRINE FORMULATIONS DEMONSTRATING STABILITY OVER TIME HAGHIGHATIAN, MINA 53d
18732227 SYSTEMS AND METHODS FOR SUPPLY CHAIN MANAGEMENT INCLUDING ERP AGNOSTIC REALTIME DATA MESH WITH CHANGE DATA CAPTURE ZEROUAL, OMAR 62d

Client Portfolio (76 clients)

Client (Assignee)Pending OAs
Ingram Micro 9
Foresee Pharmaceuticals 3
HiFiBio 3
Westlake Therapeutics (Hangzhou) Co. Limited 3
CITIZENS FINANCIAL GROUP, INC. 2
Druva 2
Qualitas Manufacturing Incorporated 2
TKR Spezialwerkzeuge GmbH 2
MEDIC Life Sciences Inc. 2
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. 2
Minghui Pharmaceutical 2
CloudBlue LLC 2
Asieris Pharmaceuticals 2
Jazz Pharmaceuticals 2
Phanes Therapeutics, Inc. 2
SHANGHAI BAO PHARMACEUTICALS CO., LTD. 2
AB2 BIO SA 2
Amphastar Pharmaceuticals, Inc. 2
NORLASE ApS 2
Tesla Biohealing, LLC 1
GRUNDFOS Holding A/S 1
Brain Healing Inc. 1
All-Cells Healing Inc. 1
Seize LLC 1
TrueRelief, LLC 1
Swisspearl Danmark Holding A/S 1
Degrees Of Freedom LLC 1
Bruker 1
Fitesa Sulmona S.r.l. 1
Salus Finance, LLC 1
Invisio A/S 1
Cytosinlab Therapeutics Co., Ltd. 1
QUÍMICA SINTÉTICA, S.A. 1
GENFIT 1
Dukane Ias, LLC 1
Jeongseok Chemical Corporation 1
Photona GmbH 1
Suzhou Sepax Technologies, Inc. 1
Shanghai Zelgen Pharma.Tech Co., Ltd. 1
UNEFI INC. 1
König Metall GmbH & Co. KG 1
OSE IMMUNOTHERAPEUTICS 1
TDK 1
SHANGHAI VISONPHARMA CO., LTD. 1
INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS 1
I-Mab 1
Roche 1
Maurer Engineering GmbH 1
Haplotype Holdings 1
SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD. 1
The Energy Authority, Inc. 1
UPC 1
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 1
ACT GENOMICS (IP) CO., LIMITED 1
Suzhou Forlong Biotechnology Co., Ltd. 1
Taprogge GmbH 1
Ulta-Lit Tree Company 1
Johnson & Johnson 1
Shanghai Precision Medicine Co., Ltd. 1
TRIOLIET B.V. 1
GENETIC INTELLIGENCE, INC 1
Minghui Pharmaceutical (Hangzhou) Limited 1
Fochon Biosciences 1
Carbon Sink Inc. 1
TOTO LTD. 1
Shanghai Zelgen Pharma. Tech Co., Ltd. 1
Sinotherapeutics Inc. 1
Frontier Biotechnologies 1
Gan & Lee Pharmaceuticals 1
GenScript 1
Inition Energy Ltd. 1
Little Engine 1
Shanghai Institute Of Meteria Medica, Chinese Academy Of Sciences 1
Sakata INX 1
Ask Sydney 1
Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI) 1

Top Art Units

Art UnitApps
16215
36284
16294
36243
16273
16433
16263
36292
36892
16752

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19399360 SYSTEMS AND METHODS FOR SUPPLY CHAIN MANAGEMENT INCLUDING ERP AGNOSTIC REALTIME DATA MESH WITH CHANGE DATA CAPTURE Ingram Micro Inc. ZEROUAL, OMAR 3629 §103 Non-Final OA Pending Nov 24, 2025
19396025 SYSTEMS AND METHODS FOR AUTOMATED CONFIGURATION TO ORDER AND QUOTE TO ORDER Ingram Micro Inc. ZEROUAL, OMAR 3628 §103 Final Rejection Pending Nov 20, 2025
19258861 SYSTEMS AND METHODS FOR MANAGING AGNOSTIC DATA FORMS FOR VENDORS Ingram Micro Inc. NGUYEN, MERILYN P 2153 §102 Final Rejection 55d Pending Jul 02, 2025
19258877 SYSTEMS AND METHODS FOR DYNAMIC SKU GENERATION IN DISTRIBUTION MANAGEMENT Ingram Micro Inc. OBAID, FATEH M 3627 Non-Final OA 70d Pending Jul 02, 2025
19085265 METHODS TO TREAT LONG-COVID AND INFLUENZA Tesla Biohealing, LLC HOFFA, ANGELA MARIE §112 Non-Final OA Pending Mar 20, 2025
19102063 PUMP FOR A ZONED HEATING OR COOLING SYSTEM AND METHOD FOR CONTROLLING A PUMP Grundfos Holding A/S NGUYEN, HOANG M 3746 §103 Non-Final OA 28d Pending Feb 07, 2025
19043248 METHODS TO TREAT PARKINSON'S DISEASE Brain Healing Inc. HOFFA, ANGELA MARIE §112 Non-Final OA Pending Jan 31, 2025
19043212 METHODS TO TREAT GENE MUTATION AND MUSCULAR DEGENERATIVE DISEASE All-Cells Healing Inc. HOFFA, ANGELA MARIE §112 Non-Final OA Pending Jan 31, 2025
19005365 AUTOMATED MULTI-PARTY DOCUMENT MANAGEMENT PLATFORM AND USER INTERACTIVE TOOL Citizens Financial Group, Inc. WALTON, CHESIREE A 3624 §103 Non-Final OA Pending Dec 30, 2024
19002457 DATA RESTORE SYSTEM Druva Inc. GUYTON, PHILIP A 2113 §101 Non-Final OA 3d overdue Pending Dec 26, 2024
18929277 SYSTEMS AND METHODS TO ORGANIZE DATA FROM MULTIPLE PLATFORMS WITH NON-TRANSITORY COMPUTER-READABLE MEDIA AND DATA ORGANIZING METHODS Seize LLC EL-CHANTI, KARMA AHMAD 3629 §101 Non-Final OA 23d overdue Pending Oct 28, 2024
18829232 SYSTEMS AND METHODS FOR GENERATING AI-DRIVEN INTEGRATED INSIGHTS Ingram Micro Inc. PRASAD, NANCY N 3624 §103 Final Rejection 53d Pending Sep 09, 2024
18843180 SYSTEM AND METHOD FOR TREATMENT BY ELECTROPHYSIOLOGICAL STIMULATION TrueRelief, LLC ALTER MORSCHAUSER, ALYSSA MARGO §103 Non-Final OA Pending Aug 30, 2024
18810601 SYSTEM AND METHOD FOR OPTIMIZED SCHEDULING OF DATA BACKUP/RESTORE Druva Inc. ELIAS, EARL L 2169 §103 Final Rejection 52d overdue Pending Aug 21, 2024
18804802 SECURITY DOOR SYSTEM Qualitas Manufacturing Incorporated FONSECA, JESSIE T 3633 §112 Non-Final OA Pending Aug 14, 2024
18837498 FIBRE CEMENT PLATE AND A WALL STRUCTURE HAVING THE FIBRE CEMENT PLATES Swisspearl Danmark Holding A/S ADAMOS, THEODORE V 3635 §103 Non-Final OA 15d overdue Pending Aug 09, 2024
18836650 CRYSTALLINE (+)-TETRABENAZINE Foresee Pharmaceuticals Co., Ltd. KENYON, JOHN S §112 Non-Final OA Pending Aug 07, 2024
18794654 KINETIC CARRIER DEVICE Degrees Of Freedom LLC CASTELLANO, STEPHEN J 3733 §102 Final Rejection 62d Pending Aug 05, 2024
18768971 SYSTEMS AND METHODS FOR DISTRIBUTION MANAGEMENT INCLUDING SPECIAL PRICING DETERMINATION Ingram Micro Inc. NELSON, FREDA ANN 3628 §101 Non-Final OA 60d Pending Jul 10, 2024
18752716 HAND-HELD PULLING AND COMPRESSION DEVICE AND MODULAR SYSTEM Tkr Spezialwerkzeuge GmbH SONG, HIMCHAN §112 Non-Final OA Pending Jun 24, 2024
18732227 SYSTEMS AND METHODS FOR SUPPLY CHAIN MANAGEMENT INCLUDING ERP AGNOSTIC REALTIME DATA MESH WITH CHANGE DATA CAPTURE Ingram Micro Inc. ZEROUAL, OMAR 3628 §103 Non-Final OA 62d Pending Jun 03, 2024
18642130 DEBRIS REMOVAL FROM HIGH ASPECT STRUCTURES Bruker Nano, Inc. BARR, MICHAEL E 1711 §112 Non-Final OA 55d Pending Apr 22, 2024
18701612 MULTI-LAYERED MATERIAL, IN PARTICULAR FOR HYGIENE/SANITARY PRODUCTS, AND MANUFACTURING METHOD FOR MAKING SUCH A MULTI-LAYERED MATERIAL Fitesa Sulmona S.r.l. PHAM, KATHERINE-PH MINH 3781 §103 Non-Final OA Pending Apr 15, 2024
18635402 INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) Medic Life Sciences Inc. AULAKH, CHARANJIT 1621 Other Non-Final OA 475d overdue Pending Apr 15, 2024
18614517 SYSTEMS AND METHODS FOR CONVERTING HARDWARE-SOFTWARE-CLOUD TO AS-A-SERVICE (AAS) Ingram Micro Inc. PRASAD, NANCY N 3624 §101 Final Rejection Pending Mar 22, 2024
18685068 ANTI-CCR8 ANTIBODIES AND USES THEREOF Hifibio, Inc. HOLTZMAN, KATHERINE ANN §103 Non-Final OA Pending Feb 20, 2024
18682647 SULFONAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Shanghai Hengrui Pharmaceutical Co., Ltd. NESTOR, DONNA MICHELLE 1627 §103 Non-Final OA Pending Feb 09, 2024
18436903 SYSTEM AND METHOD FOR CONSOLIDATION, RECONCILIATION AND PAYMENT MANAGEMENT Salus Finance, LLC POINVIL, FRANTZY 3693 §101 Non-Final OA 84d Pending Feb 08, 2024
18405848 CUSHION CONFIGURED TO BE SECURED TO AN EAR CUP OF A HEADSET AND/OR HEARING PROTECTION DEVICE Invisio A/S ANWAH, OLISA 2692 §112 Non-Final OA Pending Jan 05, 2024
18400172 PRMT5 INHIBITOR AND THE USE THEREOF Cytosinlab Therapeutics Co., Ltd. SHOWALTER, ALEXANDER KEITH 1629 DP Non-Final OA Pending Jan 02, 2024
18574513 PROCESSES FOR THE PREPARATION OF NON-STEROIDAL ANTIANDROGENS Química Sintética, S.A. NOTTINGHAM, KYLE GREGORY 1621 §103 Non-Final OA 21d Pending Dec 27, 2023
18573596 Unsaturated Hydroxamic Acid Derivatives and Their Use for the Treatment and Prevention of an Ammonia-Associated Disease or Disorder Genfit OTTON, ALICIA L 1699 §102 Non-Final OA Pending Dec 22, 2023
18570784 ANTITUMOR COMPOUND AND USE THEREOF Minghui Pharmaceutical (Shanghai) Limited MOSELEY II, NELSON B DP Non-Final OA Pending Dec 15, 2023
18541329 INTERACTIVE DATA MODELING AND COMMUNICATION PLATFORM Citizens Financial Group, Inc. CHEN, ALAN S §103 Non-Final OA Pending Dec 15, 2023
18538630 FAI MODEL DRIVEN RECOMMENDATION SYSTEM AND METHOD Cloudblue LLC LOHARIKAR, ANAND R 3689 §101 Final Rejection 6d Pending Dec 13, 2023
18532729 ULTRASONIC HORN WITH FLAT ULTRASONIC BOOSTER FOR INCREASED STIFFNESS Dukane Ias, LLC SELLS, JAMES D 1745 DP Non-Final OA Pending Dec 07, 2023
18568031 USE OF MMP INHIBITORS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME Foresee Pharmaceuticals Usa, Inc. NEAGU, IRINA 1629 Other Non-Final OA 9d overdue Pending Dec 07, 2023
18564940 ARTIFICIAL INTELLIGENCE-BASED METHOD FOR DETECTING LANE USING SPECTROGRAM PATTERN, AND APPARATUS FOR SAME Jeongseok Chemical Corporation SAUNCY, TONI DIAN 2857 §103 Non-Final OA Pending Nov 28, 2023
18561801 USE OF 5-NITRO-8-HYDROXYQUINOLINE Asieris Pharmaceuticals (Shanghai) Co., Ltd. MCMILLIAN, KARA RENITA 1623 §103 Non-Final OA Pending Nov 17, 2023
18510915 DEPOT COMPOSITIONS FOR VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) INHBITORS Foresee Pharmaceuticals Co., Ltd. MAYHEW, BRADLEY SCOTT 1621 §103 Non-Final OA Pending Nov 16, 2023
18509650 PYROELECTRIC INFRARED DETECTOR DEVICE Photona GmbH FAYE, MAMADOU 2884 §103 Final Rejection Pending Nov 15, 2023
18494851 Method of using a handheldable pulling and compressing device for repair of motor vehicle components Tkr Spezialwerkzeuge GmbH KAKARLA, BHASKAR 2116 §103 Final Rejection 9d overdue Pending Oct 26, 2023
18493764 SCALABLE REPORTING SYSTEM FOR SECURITY ANALYTICS Cloudblue LLC SAVENKOV, VADIM 2432 §103 Non-Final OA Pending Oct 24, 2023
18556895 SYNTHETIC POLYMERIC POROUS MEDIUM WITH HIERARCHICAL MULTIPLE LAYER STRUCTURE, ITS DESIGN, SYNTHESIS, MODIFICATION, AND LIQUID CHROMATOGRAPHIC APPLICATIONS Suzhou Sepax Technologies, Inc. SPIES, BRADLEY R 1777 §103 Non-Final OA Pending Oct 24, 2023
18032930 SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shanghai Zelgen Pharma.Tech Co., Ltd. WEDDINGTON, KEVIN E 1629 §102 Non-Final OA Pending Oct 23, 2023
18556605 Validating Elements Displayed on a Display Fixture UNEFI INC. BAGGOT, BREFFNI 3621 §101 Final Rejection 28d Pending Oct 20, 2023
18555278 LOW LOSS SENSIBLE HEAT STORAGE König Metall GmbH & Co. Kg RUPPERT, ERIC S 3763 §103 Final Rejection 5d Pending Oct 13, 2023
18285209 FORMULATIONS OF L-ASPARAGINASE Jazz Pharmaceuticals Ireland Limited PAGUIO FRISING, MICHELLE F 1651 §102 Non-Final OA Pending Sep 29, 2023
18463454 Anti-CD28 Humanized Antibodies Formulated for Administration to Humans Ose Immunotherapeutics DENT, ALANA HARRIS 1643 §103 Non-Final OA Pending Sep 08, 2023
18546555 PTC Heating Element, Electric Heating Device and Use of a PTC Heating Element TDK Electronics AG MACEDA, KRYSTENE NHE BANDONG 3761 Non-Final OA Pending Aug 15, 2023
18276342 PRODRUG COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Minghui Pharmaceutical (Shanghai) Limited O DELL, DAVID K 1621 §103 Final Rejection 2d overdue Pending Aug 08, 2023
18264671 DIHYDROPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shanghai Visonpharma Co., Ltd. YOUNGBLOOD, WILLIAM JUSTIN 1629 §103 Final Rejection 70d overdue Pending Aug 08, 2023
18264098 Modified Red Blood Cells and Uses Thereof For Treating Hyperuricemia and Gout Westlake Therapeutics (Hangzhou) Co. Limited LANKFORD JR, LEON B 1657 §103 Non-Final OA Pending Aug 03, 2023
18264029 Bispecific Antibodies with Charge Pairs and Uses Thereof Phanes Therapeutics, Inc. FAUST, AMBER KATHLEEN 1643 DP Non-Final OA Pending Aug 02, 2023
18261205 A BLOOD FLOW RESTRICTION SYSTEM, A METHOD FOR PERFORMING BLOOD FLOW RESTRICTION EXERCISE, AND A COMPUTER PROGRAM Institució Catalana de Recerca i Estudis Avançats LOUIS, LATOYA M 3785 §103 Non-Final OA 16d overdue Pending Jul 12, 2023
18270472 FORMULATIONS OF ANTI-CD73 ANTIBODIES I-Mab Biopharma US Limited CESARE, JOSEPH DAVID 1675 Other Non-Final OA 8d overdue Pending Jun 29, 2023
18341714 SYSTEMS AND METHODS FOR DISTRIBUTION MANAGEMENT INCLUDING SINGLE PANE OF GLASS USER INTERFACE Ingram Micro Inc. ZEROUAL, OMAR 3628 §103 Final Rejection Pending Jun 26, 2023
18258981 Methods of Enhancing Non-Viral Gene Therapy Spark Therapeutics, Inc. RONEY, CELESTE A 1612 §103 Non-Final OA 75d Pending Jun 22, 2023
18268870 STRUCTURAL DAMPER FOR PROTECTING STRUCTURES AGAINST VIBRATIONS AND STRUCTURE COMPRISING SUCH A STRUCTURAL DAMPER Maurer Engineering GmbH BURCH, MELODY M 3616 §103 Non-Final OA 22d Pending Jun 21, 2023
18333056 Method to Produce Cannabis Haploid Plants and Consequent Spontaneous or Chemically Induced Haploid/Di-Haploid in a Single Generation Haplotype Holdings Inc. KRUSE, DAVID H 1663 §112 Final Rejection 9d Pending Jun 12, 2023
17998445 PREPARATION OF BIARYL RING-LINKED AROMATIC HETEROCYCLIC DERIVATIVE AS IMMUNOMODULATOR AND USE THEREOF Shanghai Longwood Biopharmaceuticals Co., Ltd. REILLY, SOPHIA JANE 1627 §103 Final Rejection 75d Pending Jun 12, 2023
18208033 ENERGY STORAGE OPTIMIZATION SYSTEM The Energy Authority, Inc. BOOKER, KELVIN 2119 §103 Non-Final OA 52d overdue Pending Jun 09, 2023
18330418 DEVICE, A METHOD, AND A COMPUTER PROGRAM PRODUCT, FOR DETECTING AIRBORNE PARTICULATE MATTER IN AEROSOLS UNIVERSITAT POLITECNICA DE CATALUNYA LYLE, SOPHIA YUAN 1796 §102 Non-Final OA 26d overdue Pending Jun 07, 2023
18254450 DEUTERATED 2-ARYLHETEROCYCLE-3-OXO-2,3- DIHYDROPYRIDAZINE-4-CARBOXAMIDE INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Suzhou Zelgen Biopharmaceuticals Co., Ltd. FERGUSON, JALISA HOLMES 1626 §102 Final Rejection 75d Pending May 25, 2023
18027755 PHARMACEUTICAL COMBINATION AND USE THEREOF Shanghai Bao Pharmaceuticals Co., Ltd. DABKOWSKI, ERINNE R 1654 DPOther Non-Final OA Pending May 05, 2023
18034732 TARGETED SEQUENCING METHOD AND KIT THEREOF FOR DETECTING GENE ALTERATION Act Genomics (Ip) Co., Limited PHAM, KHAI QUYNH TIEN 1684 §103 Final Rejection 12d Pending May 01, 2023
18251030 Modified Red Blood Cells and Uses Thereof for Delivering Agents Westlake Therapeutics (Hangzhou) Co. Limited JACKSON III, WALTER 1638 Other Non-Final OA 9d Pending Apr 28, 2023
18250568 FC Monomer Polypeptide and Application Thereof Suzhou Forlong Biotechnology Co., Ltd. CHASE, CAROL ANN 1646 DP Non-Final OA Pending Apr 26, 2023
18249209 DOSING REGIMENS FOR CYCLIN-DEPENDENT KINASE 7 (CDK7) INHIBITORS Medic Life Sciences Inc. HEITMEIER, KENDALL NICOLE 1621 Other Non-Final OA 23d Pending Apr 14, 2023
18131026 TREATMENT OF A MASS OF MATERIAL BY PRESSING Taprogge GmbH NGUYEN, JIMMY T 3725 §103 Non-Final OA 10d overdue Pending Apr 05, 2023
18127221 DIFFUSER SECURED TO CONTAINER DRAWING OIL FRAGRANCE INTO DIFFUSER ELEMENT VIA CAPILLARY ACTION Ulta-Lit Tree Company PHAM, TUONGMINH NGUYEN 3752 §103 Non-Final OA 32d overdue Pending Mar 28, 2023
18026999 ORAL CAVITY DETECTION METHOD, ORAL CAVITY DETECTION DEVICE, AND COMPUTER-READABLE STORAGE MEDIUM Kenvue Brands LLC BUI PHO, PASCAL M 3798 §103 Non-Final OA 40d Pending Mar 17, 2023
17905521 Interferon Signaling Pathway-Related Gene Panel, Diagnostic Product and Application Thereof Shanghai Precision Medicine Co., Ltd. SULLIVAN, DENNIS JOHN 1642 §103 Non-Final OA 45d overdue Pending Feb 13, 2023
18104486 FEED MIXER WITH MIXING AUGER HAVING AN UPWARD INCREASING PITCH Trioliet B.V. COOLEY, CHARLES E 1774 §103 Non-Final OA 22d Pending Feb 01, 2023
18004532 SULFONYLBENZAMIDE DERIVATIVE AND CONJUGATE THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Hengrui Pharmaceutical Co., Ltd. HERNANDEZ, JACKSON J 1627 §103 Non-Final OA 70d overdue Pending Jan 06, 2023
18002114 Methods For Identification of Cognate Pairs of Ligands and Receptors Hifibio (Hk) Limited COOK, LISA V 1642 §103 Non-Final OA 28d Pending Dec 16, 2022
18009499 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF Genetic Intelligence, Inc. MCLEOD, AFRICA MHAIRIE 1635 §102 Final Rejection Pending Dec 09, 2022
17928423 ANTI-B7-H3 ANTIBODY AND PREPARATION THEREFOR AND USE THEREOF Minghui Pharmaceutical (Hangzhou) Limited PETRASH, HILARY ANN 1644 DP Non-Final OA Pending Nov 29, 2022
18054936 IL-18 Binding Protein (IL-18BP) In Inflammatory Diseases Ab2 Bio SA MACFARLANE, STACEY NEE 1675 §112 Final Rejection Pending Nov 14, 2022
17998234 COMPOUNDS AS BCL-2 INHIBITORS Fochon Biosciences, Ltd. STOCKTON, LAURA LYNNE 1626 §102 Final Rejection 22d Pending Nov 08, 2022
18053637 Composite Paper-Based Sorbents For CO2 Capture Carbon Sink Inc. DIGGS, TANISHA 1761 §103 Non-Final OA Pending Nov 08, 2022
17975998 STABLE INJECTABLE EPINEPHRINE FORMULATIONS INCLUDING A METAL-CHELATING AGENT Amphastar Pharmaceuticals, Inc. HAGHIGHATIAN, MINA 1616 DPOther Final Rejection Pending Oct 28, 2022
17975924 INJECTABLE EPINEPHRINE FORMULATIONS DEMONSTRATING STABILITY OVER TIME Amphastar Pharmaceuticals, Inc. HAGHIGHATIAN, MINA 1616 Other Non-Final OA 53d Pending Oct 28, 2022
17954499 MIST DEVICE, AND WATER SECTION EQUIPMENT PROVIDED WITH THE SAME Toto Ltd. DANDRIDGE, CHRISTOPHER R. 3752 §103 Non-Final OA 13d Pending Sep 28, 2022
17906435 Modified Red Blood Cells and Uses Thereof for Delivering Agents Westlake Therapeutics (Hangzhou) Co. Limited STEADMAN, DAVID J 1656 DP Non-Final OA Pending Sep 15, 2022
17755164 PYRIDAZINONE OR PYRIDAZINE COMPOUND AND DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF Shanghai Zelgen Pharma. Tech Co., Ltd. ENGLISH, CONNOR KENNEDY 1625 §112 Final Rejection Pending Sep 06, 2022
17904636 OLAPARIB PHARMACEUTICAL COMPOSITION, FORMULATION THEREOF, PREPARATION METHOD THEREOF AND USE THEREOF Sinotherapeutics Inc. JOHNSON, CHRISTOPHER LINDSAY 1691 §103 Non-Final OA 26d Pending Aug 19, 2022
17760394 Antibodies Conjugated with Fatty Acid Molecules and Uses Thereof Phanes Therapeutics, Inc. MELCHIOR, JAMES RYLAND 1644 Other Final Rejection 37d overdue Pending Aug 09, 2022
17759807 PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND Frontier Biotechnologies Inc. STOCKTON, LAURA LYNNE 1626 §103 Non-Final OA 3d overdue Pending Jul 29, 2022
17758101 Insulin Derivative Gan & Lee Pharmaceuticals Co., Ltd. HELLMAN, KRISTINA M 1654 DP Final Rejection Pending Jun 28, 2022
17809468 Apparatus for Ophthalmic Treatment Norlase ApS CHRISTIANSON, SKYLAR LINDSEY 3792 §103 Final Rejection Pending Jun 28, 2022
17758048 Method For Constructing Gene Mutation Library Nanjing Genscript Biotech Co., Ltd. FLINDERS, JEREMY C 1684 §103 Non-Final OA 8d Pending Jun 27, 2022
17757801 PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF Asieris Pharmaceuticals (Shanghai) Co., Ltd. LEE, SIN J 1613 §103 Non-Final OA 73d overdue Pending Jun 21, 2022
17843055 DEVICES AND METHODS FOR PREPARING A SLURRY AND COATING A SUBSTRATE WITH A SLURRY Inition Energy Ltd. TADESSE, YEWEBDAR T 1717 §103 Final Rejection 70d Pending Jun 17, 2022
17839166 ROLLING SHUTTER SYSTEM Qualitas Manufacturing Incorporated SHEPHERD, MATTHEW RICHARD 3634 §103 Final Rejection 12d Pending Jun 13, 2022
17589043 ELECTROCAUTERY APPARATUS AND METHOD FEATURING ULTRASOUND GUIDANCE Little Engine LLC ZIEGLER, ABIGAIL M 3794 §103 Non-Final OA Pending Jan 31, 2022
17593989 ANTI-HER2 BISPECIFIC ANTIBODY AND APPLICATION THEREOF Shanghai Bao Pharmaceuticals Co., Ltd. EDGINGTONGIORDANO, FRANCESCA 1643 §112 Non-Final OA Pending Sep 29, 2021
17442115 CAR-T-CELL THERAPY Ab2 Bio SA ZHU, JIANJIAN 1631 DP Final Rejection 23d overdue Pending Sep 22, 2021
17311580 ISOINDOLINE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION OF ISOINDOLINE COMPOUND Shanghai Institute Of Meteria Medica, Chinese Academy Of Sciences ELENISTE, PIERRE PAUL 1622 §103 Final Rejection 54d Pending Jun 07, 2021
17297104 ELECTRON BEAM CURABLE WATER-BASEDINK-JET INK COMPOSITION Sakata Inx Corporation BARZACH, JEFFREY EUGENE 1731 §103 Non-Final OA 26d Pending May 26, 2021
17284909 ITERATIVE, MULTI-USER SELECTION AND WEIGHTING RECOMMENDATION ENGINE Ask Sydney, LLC KANG, TIMOTHY J 3689 §101 Final Rejection 97d overdue Pending Apr 13, 2021
17259992 USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION Ecole Supérieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) THOMPSON, CURTIS A 1798 §103 Final Rejection 5d overdue Pending Jan 13, 2021
17260000 USE OF DROPLET SINGLE CELL EPIGENOME PROFILING FOR PATIENT STRATIFICATION Hifibio SAS THOMPSON, CURTIS A 1798 §103 Final Rejection 5d overdue Pending Jan 13, 2021
16767920 METHODS OF TREATMENT WITH ASPARAGINASE Jazz Pharmaceuticals Ireland Limited ROBINSON, HOPE A 1652 §103 Non-Final OA 34d Pending May 28, 2020
16361768 Body mounted Laser Indirect Ophthalmoscope (LIO) system Norlase ApS LEI, JIE 2872 §103 Non-Final OA 43d Pending Mar 22, 2019

Managing Ice Miller LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month